De novo acute heart failure and acutely decompensated chronic heart failure
- PMID: 26008893
- PMCID: PMC4452901
- DOI: 10.3238/arztebl.2015.0298
De novo acute heart failure and acutely decompensated chronic heart failure
Abstract
Background: Heart failure is one of the most common diseases of adults in Europe, with an overall prevalence of 1-2%. Among persons aged 60 and above, its prevalence is above 10% in men and 8% in women. Acute heart failure has a poor prognosis; it is associated with a high rate of rehospitalization and a 1-year mortality of 20-30%.
Methods: This review is based on pertinent literature, including guidelines, retrieved by a selective search in PubMed.
Results: There are different types of acute heart failure; the basic diagnostic assessment is performed at once and consists of ECG, echocardiography, and the measurement of N-terminal pro-brain natriuretic peptide (NTproBNP) and troponin levels. The most common causes of decompensation are arrhythmia, valvular dysfunction, and acute cardiac ischemia, each of which accounts for 30% of cases. The potential indication for immediate revascularization should be carefully considered in cases where acute heart failure is due to coronary heart disease. The basic treatment of acute heart failure is symptomatic, with the administration of oxygen, diuretics, and vasodilators. Ino-tropic agents, vasopressors, and temporary mechanical support for the circulatory system are only used to treat cardiogenic shock.
Conclusion: The treatment of acute heart failure is markedly less evidence-based than that of chronic heart failure. Newer treatment approaches that are intended to improve outcomes still need to be tested in multicenter trials.
Figures





Comment in
-
Which Patients Will Benefit?Dtsch Arztebl Int. 2016 Jan 22;113(3):39. doi: 10.3238/arztebl.2016.0039a. Dtsch Arztebl Int. 2016. PMID: 26857512 Free PMC article. No abstract available.
-
The Renaissance of Digitoxin Is Overdue.Dtsch Arztebl Int. 2016 Jan 22;113(3):39. doi: 10.3238/arztebl.2016.0039b. Dtsch Arztebl Int. 2016. PMID: 26857513 Free PMC article. No abstract available.
-
Rapid Application Is Crucial.Dtsch Arztebl Int. 2016 Jan 22;113(3):39-40. doi: 10.3238/arztebl.2016.0039c. Dtsch Arztebl Int. 2016. PMID: 26857514 Free PMC article. No abstract available.
-
In Reply.Dtsch Arztebl Int. 2016 Jan 22;113(3):40. doi: 10.3238/arztebl.2016.0040. Dtsch Arztebl Int. 2016. PMID: 26857515 Free PMC article. No abstract available.
Similar articles
-
[Acute heart failure].Medicina (Kaunas). 2006;42(8):682-91. Medicina (Kaunas). 2006. PMID: 16963836 Review. Lithuanian.
-
Current treatment options for early management in acute decompensated heart failure.Can J Cardiol. 2008 Jul;24 Suppl B(Suppl B):9B-14B. doi: 10.1016/s0828-282x(08)71023-7. Can J Cardiol. 2008. PMID: 18629382 Free PMC article. Review.
-
[The new ESC Guidelines for acute and chronic heart failure 2016].Herz. 2016 Dec;41(8):655-663. doi: 10.1007/s00059-016-4496-3. Herz. 2016. PMID: 27858115 Review. German.
-
Current ESC/ESICM and ACCF/AHA guidelines for the diagnosis and management of acute heart failure in adults--are there differences?Pol Arch Med Wewn. 2009 Sep;119(9):569-73. Pol Arch Med Wewn. 2009. PMID: 19776702 Review.
-
[Therapeutic strategies in acute decompensated heart failure and cardiogenic shock].Internist (Berl). 2010 Aug;51(8):963-74. doi: 10.1007/s00108-009-2537-1. Internist (Berl). 2010. PMID: 20652210 Review. German.
Cited by
-
Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure.Biomolecules. 2021 Nov 16;11(11):1701. doi: 10.3390/biom11111701. Biomolecules. 2021. PMID: 34827701 Free PMC article.
-
Additive harmful effects of acute kidney injury and acute heart failure on mortality in hospitalized patients.Kidney Res Clin Pract. 2022 Mar;41(2):188-199. doi: 10.23876/j.krcp.21.111. Epub 2021 Dec 1. Kidney Res Clin Pract. 2022. PMID: 34974653 Free PMC article.
-
Treatment outcome and its predictors among patients of acute heart failure at a tertiary care hospital in Ethiopia: a prospective observational study.BMC Cardiovasc Disord. 2020 Jan 20;20(1):16. doi: 10.1186/s12872-019-01318-x. BMC Cardiovasc Disord. 2020. PMID: 31959121 Free PMC article.
-
Correlation between Serum LP-PLA2 and sST2 Levels and the Condition of Patients with Acute Heart Failure and Their Prognostic Value.Evid Based Complement Alternat Med. 2021 Oct 18;2021:8267776. doi: 10.1155/2021/8267776. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9852951. doi: 10.1155/2023/9852951. PMID: 34707676 Free PMC article. Retracted.
-
A New Biomarker Tool for Risk Stratification in "de novo" Acute Heart Failure (OROME).Front Physiol. 2022 Jan 13;12:736245. doi: 10.3389/fphys.2021.736245. eCollection 2021. Front Physiol. 2022. PMID: 35095543 Free PMC article.
References
-
- Braunwald, E. Heart failure. J Am Coll Cardiol HF. 2013;1:1–20. - PubMed
-
- Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115. - PubMed
-
- Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725–2736. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical